Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maturation of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in 3D collagen matrix: Effects of niche cell supplementation and mechanical stimulation.

Acta biomaterialia·2016
Same author

Nitric Oxide-cGMP-PKG Pathway Acts on Orai1 to Inhibit the Hypertrophy of Human Embryonic Stem Cell-Derived Cardiomyocytes.

Stem cells (Dayton, Ohio)·2015
Same author

[Cell technologies in complex treatment of venous trophic ulcers].

Khirurgiia·2011
Same author

New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome.

Mucosal immunology·2011
Same author

HCN-encoded pacemaker channels: from physiology and biophysics to bioengineering.

The Journal of membrane biology·2007
Same author

Molecular architecture of the voltage-dependent Na channel: functional evidence for alpha helices in the pore.

The Journal of general physiology·2001

Related Experiment Video

Updated: May 21, 2026

Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection
08:52

Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection

Published on: February 17, 2015

Gene- and cell-based bio-artificial pacemaker: what basic and translational lessons have we learned?

R A Li1

  • 1Center of Cardiovascular Research, Mount Sinai School of Medicine, New York, NY 10029, USA. ronald.li@mssm.edu

Gene Therapy
|June 8, 2012
PubMed
Summary
This summary is machine-generated.

Researchers are developing bio-artificial pacemakers using gene and cell therapies as alternatives to electronic devices. These approaches aim to restore normal heart rhythms, overcoming limitations of current pacemaker technology.

More Related Videos

Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices
09:35

Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices

Published on: June 16, 2020

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues
12:28

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues

Published on: June 2, 2023

Related Experiment Videos

Last Updated: May 21, 2026

Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection
08:52

Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection

Published on: February 17, 2015

Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices
09:35

Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices

Published on: June 16, 2020

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues
12:28

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues

Published on: June 2, 2023

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Biotechnology

Background:

  • Normal heart rhythms originate from specialized sino-atrial node pacemaker cells.
  • Dysfunctional pacemaker cells cause rhythm disorders like sick-sinus syndrome (SSS), often requiring electronic pacemakers.
  • Electronic pacemakers have limitations including battery life, lead issues, and lack of autonomic response.

Purpose of the Study:

  • To review gene- and cell-based strategies for creating bio-artificial pacemakers.
  • To explore the potential of pluripotent stem cells and specific gene families in pacemaker reconstruction.
  • To discuss biological insights and translational potential for regenerative therapies.

Main Methods:

  • Review of gene- and cell-based approaches for bio-artificial pacemaker development.
  • Focus on pluripotent stem cells and hyperpolarization-activated cyclic nucleotide-gated (HCN) genes.
  • Analysis of basic biological principles and translational regenerative medicine.

Main Results:

  • Gene- and cell-based therapies show promise as alternatives to electronic pacemakers.
  • Pluripotent stem cells offer a versatile platform for generating functional pacemaker cells.
  • HCN gene family research is crucial for understanding and recreating pacemaker function.

Conclusions:

  • Bio-artificial pacemakers represent a promising alternative to electronic devices.
  • Further research into stem cell biology and gene therapy is essential for clinical translation.
  • Regenerative approaches hold potential for treating heart rhythm disorders effectively.